SUBMIT BOOK PROPOSAL
Online Store
benthambooks logo

Site Breadcrumb

Frontiers in Cardiovascular Drug Discovery
View Sample

Editors: Atta-ur-Rahman , M. Iqbal Choudhary

Frontiers in Cardiovascular Drug Discovery

Volume 2
eBook: US $59 Special Offer (PDF + Printed Copy): US $161
Printed Copy: US $131
Library License: US $236
ISSN: 2452-3267 (Print)
ISSN: 1879-6648 (Online)
ISBN: 978-1-60805-969-0 (Print)
ISBN: 978-1-60805-968-3 (Online)
Year of Publication: 2015
DOI: 10.2174/97816080596831150201
Rate This Book

Introduction

Frontiers in Cardiovascular Drug Discovery is an eBook series devoted to publishing the latest and the most important advances in Cardiovascular drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The eBook series should prove to be of interest to all pharmaceutical scientists involved in research in cardiovascular drug design and discovery. Each volume is devoted to the major advances in cardiovascular drug design and discovery. The eBook series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.

Indexed in: EMBASE


eBook: US $59 Special Offer: US $161 Printed Copy: US $131 Library License: US $236

Contributors

Editor(s):
FRS Atta-ur-Rahman
University of Cambridge
Kings College
Cambridge
UK


M. Iqbal Choudhary
Biological Sciences
H.E.J. Research Institute of Chemistry
University of Karachi
Karachi, 75270
Pakistan



Contributor(s):
A. Doltra
Deutsches Herzzentrum Berlin, Department of Internal Medicine/Cardiology
Berlin
Germany


Alexander N. Orekhov
Institute for Atherosclerosis Research, Skolkovo Innovative Center
Moscow
Russia
/
Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences
Moscow
Russia


Alexandra A. Melnichenko
Institute for Atherosclerosis Research, Skolkovo Innovative Center
Moscow
Russia
/
Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences
Moscow
Russia


Dingguo Zhang
Department of Cardiology
the First Affiliated Hospital of Nanjing Medical University
Nanjing
China


E. Fleck
Deutsches Herzzentrum Berlin, Department of Internal Medicine/Cardiology
Berlin
Germany


Gregory Y.H. Lip
Centre for Cardiovascular Sciences, City Hospital
University of Birmingham
Birmingham B18 7QH,
UK


Liansheng Wang
Department of Cardiology
the First Affiliated Hospital of Nanjing Medical University
Nanjing
China


Marija M. Polovina
Cardiology Clinic
Clinical Center of Serbia
Belgrade
Serbia


Marina M. Licina
Cardiology Clinic
Clinical Center of Serbia
Belgrade
Serbia


Milica S. Prostran
Department of Pharmacology, Clinical Pharmacology and Toxicology
Faculty of Medicine, University of Belgrade
11000 Belgrade
Serbia


S. Kelle
Deutsches Herzzentrum Berlin, Department of Internal Medicine/Cardiology
Berlin
Germany


Tatjana S. Potpara
Faculty of Medicine, University of Belgrade
Serbia
/
Cardiology Clinic, Clinical Center of Serbia
Belgrade
Serbia


Yuri V. Bobryshev
Moscow
Russia
/
Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences
Moscow
Russia
/
Faculty of Medicine, School of Medical Sciences, University of New South Wales
Sydney
Australia
/
N. P. Ogaryov Mordovian State University, Biological Faculty
Saransk, Republic of Mordovia
Russia


Zhijian Yang
Department of Cardiology
the First Affiliated Hospital of Nanjing Medical University
Nanjing
China